Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Meghan N Jeffres"'
Autor:
Miranda R Norvell, Melissa Porter, Madison H Ricco, Ryan C Koonce, Craig A Hogan, Eric Basler, Megan Wong, Meghan N Jeffres
Publikováno v:
Open Forum Infectious Diseases.
Background Cefazolin is a first-line agent for prevention of surgical site infections (SSIs) after total joint arthroplasty. Patients labeled as allergic to beta-lactam antibiotics frequently receive clindamycin or vancomycin perioperatively due to t
Autor:
Mary L Staicu, Meghan N Jeffres, Bruce M Jones, Kayla R Stover, Jamie L Wagner, Christopher M Bland
Publikováno v:
JAC-Antimicrobial Resistance. 5
BackgroundThe clinical and financial consequences associated with a penicillin-allergy label are increasingly evident and have garnered support from international organizations to prioritize penicillin-allergy delabelling programmes. Most settings la
Publikováno v:
INNOVATIONS in Pharmacy, Vol 9, Iss 2 (2018)
The Center for the Advancement of Pharmacy Education 2013 Affective Domain mandates students develop self-awareness of personal attributes affecting professional growth. Students should self-identify needs, create and implement goals, and evaluate su
Externí odkaz:
https://doaj.org/article/3d5d8214743b4edfa6d6d26c09724e39
Autor:
Meghan N Jeffres, Melissa Porter, Madison Ricco, Miranda Norvell, Ryan Koonce, Eric Bassler, Craig Hogan
Publikováno v:
Open Forum Infectious Diseases. 9
Background Perioperative antibiotics reduce surgical site infections after hip and knee arthroplasty. Clindamycin is routinely used as a perioperative antibiotic in patients with beta-lactam allergy labels instead of first-line antibiotics like cefaz
Autor:
Meghan N Jeffres, Melissa Porter, Madison Ricco, Miranda Norvell, Craig Hogan, Eric Bassler, Ryan Koonce
Publikováno v:
Open Forum Infectious Diseases. 9
Background Prosthetic joint infection (PJI) is a devastating complication following knee and hip arthroplasty. Perioperative antibiotics are routinely used in an effort to decrease the risk of surgical site infections (SSI), including superficial ski
Autor:
José Pablo Díaz-Madriz, Jeffrey C Pearson, Meghan N Jeffres, Melissa D Johnson, Scott J Bergman, Eduardo Savio
Publikováno v:
Open Forum Infectious Diseases. 9
Background Antimicrobial stewardship programs (AMS) in Latin America have varying degrees of development. One significant barrier is the lack of clinical pharmacists with specialized training in infectious diseases, as there are no residency programs
Autor:
Lucas E Orth, Amanda S Ellingson, Sara F Azimi, Joseph T Martinez, Amal A Alhadad, Brenda C Tran, Chase W Allen, Cecilia T Nguyen, Tony Duong, Jordan S Burkdoll, Jenny Yoo, Allison B Blackmer, Meghan N Jeffres
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 79(15)
Purpose The aim of this review was to build upon previous literature describing the maximum duration for which refrigerated medications can tolerate room temperature excursions while maintaining stability and potency. Methods During a 12-month period
Publikováno v:
Open Forum Infectious Diseases. 9
BackgroundFluoroquinolones are the second-most prescribed antimicrobial and are frequently associated with causing hypersensitivity reactions. Existing evidence regarding cross-reactivity of fluoroquinolones is limited, offering clinicians little gui
Autor:
Katherine J. Sullivan, Meghan N. Jeffres, Robert P. Dellavalle, Robert Valuck, Heather D. Anderson
Publikováno v:
Antibiotics, Vol 7, Iss 1, p 11 (2018)
Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and overlap syndrome (SJS-TEN) are rare, serious skin and mucosa break-down conditions frequently associated with antibiotic use. The role of nonprescription medications alone, or in c
Externí odkaz:
https://doaj.org/article/02cfb60be48040c6bc899e88890ea51a
Publikováno v:
Open forum infectious diseases. 9(4)
Fluoroquinolones are the second-most prescribed antimicrobial and are frequently associated with causing hypersensitivity reactions. Existing evidence regarding cross-reactivity of fluoroquinolones is limited, offering clinicians little guidance in u